LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.78 | 771.67 | 1255 | 1459 | 0.8597 | 0.6969 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.78 | 771.67 | 1270 | 1459 | 0.8700 | 0.7190 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.00 | 771.67 | 1317 | 1585 | 0.8307 | 0.6729 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.00 | 771.67 | 1351 | 1585 | 0.8521 | 0.7144 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.22 | 771.67 | 1350 | 1741 | 0.7753 | 0.6102 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.22 | 771.67 | 1394 | 1741 | 0.8005 | 0.6548 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.44 | 771.67 | 1399 | 1910 | 0.7321 | 0.5759 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.44 | 771.67 | 1429 | 1910 | 0.7478 | 0.6016 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.66 | 771.67 | 1446 | 2141 | 0.6752 | 0.5318 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.66 | 771.67 | 1472 | 2141 | 0.6874 | 0.5505 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.89 | 771.67 | 1464 | 2397 | 0.6106 | 0.4792 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.89 | 771.67 | 1516 | 2397 | 0.6323 | 0.5111 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.11 | 771.67 | 1501 | 2675 | 0.5611 | 0.4491 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.11 | 771.67 | 1623 | 2675 | 0.6067 | 0.5137 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.33 | 771.67 | 1554 | 2939 | 0.5287 | 0.4374 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.33 | 771.67 | 1696 | 2939 | 0.5770 | 0.5040 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.55 | 771.67 | 1683 | 3196 | 0.5265 | 0.4627 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.55 | 771.67 | 1768 | 3196 | 0.5531 | 0.4983 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.78 | 771.67 | 1744 | 3499 | 0.4983 | 0.4533 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.78 | 771.67 | 1804 | 3499 | 0.5155 | 0.4760 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.00 | 771.67 | 1829 | 3884 | 0.4708 | 0.4479 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.00 | 771.67 | 1891 | 3884 | 0.4868 | 0.4687 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.22 | 771.67 | 1879 | 4299 | 0.4370 | 0.4321 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.22 | 771.67 | 1975 | 4299 | 0.4593 | 0.4612 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.44 | 771.67 | 1937 | 4738 | 0.4088 | 0.4212 | MN20160304_L01 | E05 |